South Korea-based ADEL said late on Monday that it has entered a $1.04 billion partnership with French drugmaker Sanofi to ...

An announcement from AEON Biopharma ( ($AEON) ) is now available. On December 15, 2025, AEON Biopharma Inc. announced an Exchange Agreement with ...

A catalyst for technology-based economic development in life sciences . In 1984, three of North Carolina’s largest ...

Novartis has operated in North Carolina for more than two decades, delivering gene therapies and other lifesaving treatments ...

Fortress and its majority-owned subsidiary, Cyprium Therapeutics, said the FDA has accepted an NDA resubmission for CUTX-101, or copper histidinate, a treatment for children who suffer from Menkes ...

The deal revolves around a drug Sobi claimed could become the “therapy of choice” for people whose gout symptoms persist ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

FOXO Technologies Inc. (OTC: FOXO) (the 'Company”), announces Chief Executive Officer Seamus Lagan has provided the following Year-End Review to shareholders: ...

Dren Bio, a private biotech company, said on Monday it has entered into a strategic collaboration with Sanofi to develop therapies for autoimmune diseases in a deal worth up to $1.7 billion.

Swedish Orphan Biovitrum AB (STO: SOBI) recently announced that it has entered into an acquisition agreement with ...

When biotechs and major pharma companies need to fast-track early drug trials, they're increasingly skipping Boston and ...